Complexes of the [(η 5 -C 5 H 4 COOR)M(CO) 3 ] type (M = 99m Tc, Re; R = targeting function) are basic bioorganometallic structures with the potential of combining molecular imaging ( 99m Tc) with therapy (cold Re or 186/188 Re). So far, the single carboxylate group on the cyclopentadienyl ring (Cp − ) limited targeting to one function. The concept of Cp − as a scaffold for attaching biological molecules could be extended substantially with two or more functionalities bound to the Cp − ligand. Accordingly, the rarely studied bis-substituted cyclopentadienyl ligands [C 5 H 3 (1,2-COOMe) 2 ] − and [C 5 H 3 (1,3-COOMe) 2 ] − were synthesized and their coordination to the fac-{M(CO) 3 } + moiety was studied in water. Both ligands are deprotonated at physiological pH and do not undergo Diels−Alder reactions. In water, they react directly with [Re(OH 2 ) 3 (CO) 3 ] + to form [(η 5 -C 5 H 3 {1,2-COOMe} 2 )Re(CO) 3 ] and [(η 5 -C 5 H 3 {1,3-COOMe} 2 )Re(CO) 3 ]. Controlled hydrolysis at neutral to alkaline pH gives the monoesters and fully hydrolyzed [(η 5 -C 5 H 3 {1,2-COOH} 2 )Re(CO) 3 ] and [(η 5 -C 5 H 3 {1,3-COOH} 2 )Re(CO) 3 ]. Thermal treatment leads to decarboxylation and formation of [(η 5 -C 5 H 4 COOH)Re(CO) 3 ]. The corresponding 99m Tc homologues are directly accessible under slightly acidic conditions from [ 99m TcO 4 ] − in high yields. In the presented strategy, the Cp − ring acts as a scaffold for attaching multiple targeting agents or pharmacophores at the same time.
■ INTRODUCTIONThe evaluation of new molecular imaging agents and medicinal inorganic compounds for therapy is a driving force in bioorganometallic chemistry. 1 Metal-based imaging agents and metal complexes currently used for therapy generally do not have much in common and have very distinct structures. A recent extension to the concept of imaging and therapy is theranostics in which both, diagnosis and therapy, are combined in one single compound, typically a nanomaterial. 2,3 Homologous complexes of two elements, one suited for diagnosis and one for therapy, represent an attractive molecular alternative to nanomaterial-based theranostics. 2,4−6 Technetium and rhenium represent such a "matched-pair", in that they form isostructural and highly robust complexes in low oxidation states. As structural mimics of pharmaceutical lead compounds, the cold (or hot 186 Re and 188 Re) rhenium complexes are therapeutically active, while the 99m Tc homologues are the imaging congener. According to this theranostic concept, a metal complex is an integral part of a lead structure; consequently, the complex must be small. The "innocent" cyclopentadienyl (Cp − ) ligand is, therefore, attractive as [(Cp-R) 99m Tc(CO) 3 ] can be integrated into lead structures and mimic phenyl rings, for example. 7−11 Cyclopentadienyl complexes are robust, and targeting functionalities can be attached, as has been shown with many bioconjugates of ferrocene. 9,12−16 We previously reported studies on the preparation of [(Cp-R) 99m Tc(CO) 3 ] and its rhenium homologues. 10,11,...